We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+24.52%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$11.9B
AUM Growth
-$101M
(-0.84%)
Cap. Flow
-$1.72B
Cap. Flow
% of AUM
-14.47%
Top 10 Holdings %
Top 10 Hldgs %
16.8%
Holding
1,692
New
482
Increased
315
Reduced
482
Closed
413
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$242M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$187M |
| 3 |
AstraZeneca
AZN
|
+$163M |
| 4 |
Lockheed Martin
LMT
|
+$162M |
| 5 |
S&P Global
SPGI
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$234M |
| 2 |
Johnson & Johnson
JNJ
|
+$185M |
| 3 |
Mercado Libre
MELI
|
+$136M |
| 4 |
Procter & Gamble
PG
|
+$128M |
| 5 |
Shopify
SHOP
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.38% |
| 2 | Healthcare | 15.54% |
| 3 | Consumer Discretionary | 12.1% |
| 4 | Industrials | 11.12% |
| 5 | Communication Services | 10.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Navient
NAVI
$867M
| $6.11M | 0.05% |
621,903
-52,231
| -8% | -$496K |
|
402
Corcept Therapeutics
CORT
$11.9B
| $6.11M | 0.05% |
233,405
-119,498
| -34% | -$2.52M |
|
403
First Industrial Realty Trust
FR
$8.4B
| $6.1M | 0.05% |
+144,770
| New | +$6.06M |
|
404
ConocoPhillips
COP
$150B
| $6.07M | 0.05% |
151,875
+122,544
| +418% | +$4.52M |
|
405
Credit Acceptance
CACC
$6.05B
| $6.05M | 0.05% |
+17,472
| New | +$5.71M |
|
406
StoneCo
STNE
$2.49B
| $6.01M | 0.05% |
71,610
-34,517
| -33% | -$2.31M |
|
407
Constellation Brands
STZ
$23.3B
| $6M | 0.05% |
27,408
-16,548
| -38% | -$3.25M |
|
408
HP
HPQ
$28.6B
| $5.98M | 0.05% |
243,345
+190,372
| +359% | +$4M |
|
409
Boot Barn
BOOT
$4.92B
| $5.91M | 0.05% |
136,311
+113,950
| +510% | +$4.29M |
|
410
Ambarella
AMBA
$3.6B
| $5.88M | 0.05% |
+64,070
| New | +$4.49M |
|
|
HIBB
411
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $5.84M | 0.05% |
126,535
+34,102
| +37% | +$1.52M |
|
412
eHealth
EHTH
$38.8M
| $5.84M | 0.05% |
82,710
-5,553
| -6% | -$422K |
|
413
Genmab
GMAB
$19.3B
| $5.84M | 0.05% |
143,525
-39,109
| -21% | -$1.46M |
|
|
EVRI
414
DELISTED
Everi Holdings
EVRI
| $5.79M | 0.05% |
419,095
+359,682
| +605% | +$3.91M |
|
415
Personalis
PSNL
$1.54B
| $5.78M | 0.05% |
157,832
+26,623
| +20% | +$805K |
|
416
Teradata
TDC
$2.57B
| $5.78M | 0.05% |
257,099
-62,370
| -20% | -$1.34M |
|
417
Riot Platforms
RIOT
$7.21B
| $5.76M | 0.05% |
+339,015
| New | +$2.25M |
|
418
Magnite
MGNI
$3.53B
| $5.73M | 0.05% |
+186,568
| New | +$2.82M |
|
419
Lennar Class A
LEN
$21.1B
| $5.72M | 0.05% |
+77,524
| New | +$5.81M |
|
420
New Oriental
EDU
$8.33B
| $5.67M | 0.05% |
30,527
-8,266
| -21% | -$1.39M |
|
421
Yelp
YELP
$1.32B
| $5.67M | 0.05% |
173,399
-5,324
| -3% | -$140K |
|
422
Bio-Techne
TECH
$11.2B
| $5.63M | 0.05% |
70,972
-3,304
| -4% | -$239K |
|
423
Insulet
PODD
$10.2B
| $5.6M | 0.05% |
+21,919
| New | +$5.44M |
|
|
TMX
424
DELISTED
Terminix Global Holdings, Inc.
TMX
| $5.59M | 0.05% |
109,650
+92,236
| +530% | +$4.45M |
|
425
Nu Skin
NUS
$236M
| $5.59M | 0.05% |
102,337
+2,480
| +2% | +$130K |
|
Similar funds
VAI
JG
OAG
Voloridge Investment Management's Q4 2020 Portfolio in Review
As of Q4 2020, Voloridge Investment Management held 1,692 positions worth $11.9B, down 0.84% from $12B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Voloridge Investment Management withdrew a net $1.72B in Q4 2020, closing 413 positions and reducing 482 holdings. Its most notable exit was Wells Fargo, an estimated $111M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Voloridge Investment Management opened a new position in AstraZeneca worth $154M.
- Voloridge Investment Management's largest Q4 2020 buy was AstraZeneca: 1,542,881 shares worth $154M.
- Voloridge Investment Management added most to Microsoft in Q4 2020, an estimated $242M increase.
- Voloridge Investment Management's biggest Q4 2020 reduction was Citigroup, cutting an estimated $234M.
- Voloridge Investment Management fully exited Wells Fargo in Q4 2020, selling an estimated $111M.
- Voloridge Investment Management's ten largest holdings make up 17% of its $11.9B portfolio in Q4 2020.
- Voloridge Investment Management opened 482 new positions and closed 413 in Q4 2020.
- Voloridge Investment Management's portfolio value fell 0.84% quarter-over-quarter to $11.9B.
Based on Voloridge Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.